PRKCD and metabolic dysfunction-associated steatohepatitis: Increasing studies have confirmed that protein kinase C-δ (PKC-δ), one of novel (δ, ε, and θ) PKC isoforms which triggered by diacylglycerol (DAG) acutely and chronically [8], can be involved in the regulation of the course of NASH through ERS pathway.